acetylcysteine has been researched along with clioquinol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, SH; Chen, SY; Chen, Y; Gu, LQ; Huang, ZS; Li, YP; Ou, TM; Tan, JH | 1 |
| Duckett, CS; Hucks, GE; Kenneth, NS; Kocab, AJ; McCollom, AL | 1 |
3 other study(ies) available for acetylcysteine and clioquinol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cell Line, Tumor; Chelating Agents; Curcumin; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Structure; Peptide Fragments; Reactive Oxygen Species; Stereoisomerism; Structure-Activity Relationship | 2011 |
Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways.
Topics: Acetylcysteine; Animals; Cell Line; Cell Line, Tumor; Clioquinol; Copper; Free Radical Scavengers; Humans; I-kappa B Proteins; Ionophores; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Phosphorylation; Signal Transduction; X-Linked Inhibitor of Apoptosis Protein | 2014 |